Pharmacokinetics and Metabolic Activation of Capecitabine

ABSTRACT: The objective of this pharmacokinetic study is to exclude a possible influence of CETUX on the plasma disposition and metabolic activation of Capecitabine (CCB) and when this regimen is given combined with Oxaliplatin (OxPt).

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2123891 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR